S100B protein as a screening tool for computed tomography findings after mild traumatic brain injury: Systematic review and meta-analysis

References

• Kraus JF, McArthur DL. Epidemiology of brain injury. Neurological Trauma 1996;2:3–18
   Google Scholar
• Corrigan JD, Selassie AW, Orman JAL. The epidemiology of traumatic brain injury. Journal of Head Trauma Rehabilitation 2010;25:72–80
   PubMed Web of Science ®Google Scholar
• Thornhill S, Teasdale GM, Murray GD, McEwen J, Roy CW, Penny KI. Disability in young people and adults one year after head injury: Prospective cohort study. British Medical Journal 2000;320:1631–1635
   PubMed Web of Science ®Google Scholar
• Borczuk P. Predictors of intracranial injury in patients with mild head trauma. Annals of Emergency Medicine 1995;25:731–736
   PubMed Web of Science ®Google Scholar
• Stein SC, Ross SE. The value of computed tomographic scans in patients with low-risk head injuries. Neurosurgery 1990;26:638–640
   PubMed Web of Science ®Google Scholar
• Smith-Bindman R. Is computed tomography safe. New England Journal of Medicine 2010;363:1–4
   PubMed Web of Science ®Google Scholar
• Reinus WR, Wippold II FJ, Erickson KK. Practical selection criteria for noncontrast cranial computed tomography in patients with head trauma. Annals of Emergency Medicine 1993;22:1148–1155
   PubMed Web of Science ®Google Scholar
• Honda M, Tsuruta R, Kaneko T, Kasaoka S, Yagi T, Todani M, Fujita M, Izumi T, Maekawa T. Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase. Journal of Trauma 2010;69:104–109
   PubMed Web of Science ®Google Scholar
• Gyorgy A, Ling G, Wingo D, Walker J, Tong L, Parks S, Januszkiewicz A, Baumann R, Agoston DV. Time-dependent changes in serum biomarker levels after blast traumatic brain injury. Journal of Neurotrauma 2011;28:1121–1126
   PubMed Web of Science ®Google Scholar
• Ingebrigtsen T, Romner B, Marup-Jensen S, Dons M, Lundqvist C, Bellner J, Alling C, Børgesen SE. The clinical value of serum S-100 protein measurements in minor head injury: A Scandinavian multicentre study. Brain Injury 2000;14:1047–1055
   PubMed Web of Science ®Google Scholar
• Böhmer AE, Oses JP, Schmidt AP, Perón CS, Krebs CL, Oppitz PP, D'Avila TT, Souza DO, Portela LV, Stefani MA. Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury. Neurosurgery 2011;68:1624–1631
   PubMed Web of Science ®Google Scholar
• Szymanski PT, Kuppast B, Ahmed SA, Khalifa S, Fahmy H. Sarcophine-Diol, a skin cancer chemopreventive agent, inhibits proliferation and stimulates apoptosis in mouse melanoma B16F10 Cell Line. Marine Drugs 2011;10:1–19
   PubMed Web of Science ®Google Scholar
• Dempsey BR, Shaw GS. Identification of calcium-independent and calcium-enhanced binding between S100B and the dopamine D2 receptor. Biochemistry 2011;50:9056–9065
   PubMed Web of Science ®Google Scholar
• Zongo D, Ribéreau-Gayon R, Masson F, Laborey M, Contrand B, Salmi LR, Montaudon D, Beaudeux JL, Meurin A, Dousset V, Loiseau H, Lagarde E. S100-B protein as a screening tool for the early assessment of minor head injury. Annals of Emergency Medicine 2012;59:209–218
   PubMed Web of Science ®Google Scholar
• Zhang Z, Li W, Mu J, Song J. Increased serum S100B concentration correlates with hippocampal S100B overexpression and cellular damage following chronic cerebral hypoperfusion. Neurology, Psychology & Brain Research 2012;18:114–119
   Google Scholar
• Koh SX, Lee JK. S100B as a marker for brain damage and blood–brain barrier disruption following exercise. Sports Medicine 2014;44:369–385
   PubMed Web of Science ®Google Scholar
• Undén J, Romner B. Can low serum levels of S100B predict normal CT findings after minor head injury in adults?: An evidence-based review and meta-analysis. Journal of Head Trauma Rehabilitation 2010;25:228–240
   PubMed Web of Science ®Google Scholar
• Heidari K, Asadollahi S, Jamshidian M, Abrishamchi SN, Nouroozi M. Prediction of neuropsychological outcome after mild traumatic brain injury using clinical parameters, serum S100B protein and findings on computed tomography. Brain Injury 2014;10:1–8
   Google Scholar
• Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. Annals of International Medicine 2009;151:W-65–W-94
   Web of Science ®Google Scholar
• Viswanathan M, Ansari MT, Berkman ND, Chang S, Hartling L, McPheeters LM, Santaguida PL, Shamliyan T, Singh K, Tsertsvadze A, et al. Agency for Healthcare Research and Quality Methods Guide for Comparative Effectiveness Reviews. Rockville, MC: Quality AfHRa; 2012
   Google Scholar
• Vos PE, Battistin L, Birbamer G, Gerstenbrand F, Potapov A, Prevec T, Stepan ChA, Traubner P, Twijnstra A, Vecsei L, et al.; European Federation of Neurological Societies. EFNS guideline on mild traumatic brain injury: Report of an EFNS task force. European Journal of Neurology 2002;9:207–219
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Version 5.1. 0. The Cochrane Collaboration; 2011 . [2011-03-01]. http://www.cochrane/hand-book.org. accessed 2013
   Google Scholar
• Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology 2005;5:13
   PubMedGoogle Scholar
• Sistrom CL, Mergo PJ. A simple method for obtaining original data from published graphs and plots. American Journal of Roentgenology 2000;174:1241–1244
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. British Medical Journal 2003;327:557--560
   PubMed Web of Science ®Google Scholar
• Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 1997;315:629–634
   PubMed Web of Science ®Google Scholar
• Babcock L, Byczkowski T, Wade SL, Ho M, Bazarian JJ. Inability of S100B to predict postconcussion syndrome in children who present to the emergency department with mild traumatic brain injury: A brief report. Pediatric Emergency Care 2013;29:458–461
   PubMed Web of Science ®Google Scholar
• Bazarian JJ, Beck C, Blyth B, von Ahsen N, Hasselblatt M. Impact of creatine kinase correction on the predictive value of S-100B after mild traumatic brain injury. Restorative Neurology & Neuroscience 2006;24:163–172
   PubMed Web of Science ®Google Scholar
• Bazarian JJ, Zemlan FP, Mookerjee S, Stigbrand T. Serum S-100B and cleaved-tau are poor predictors of long-term outcome after mild traumatic brain injury. Brain Injury 2006;20:759–765
   PubMed Web of Science ®Google Scholar
• Begaz T, Kyriacou DN, Segal J, Bazarian JJ. Serum biochemical markers for post-concussion syndrome in patients with mild traumatic brain injury. Journal of Neurotrauma 2006;23:1201–1210
   PubMed Web of Science ®Google Scholar
• Biberthaler P, Mussack T, Wiedemann E, Gilg T, Soyka M, Koller G, Pfeifer KJ, Linsenmaier U, Mutschler W, Gippner-Steppert C, et al. Elevated serum levels of S-100B reflect the extent of brain injury in alcohol intoxicated patients after mild head trauma. Shock 2001;16:97–101
   PubMed Web of Science ®Google Scholar
• Bouvier D, Fournier M, Dauphin JB, Amat F, Ughetto S, Labbé A, Sapin V. Serum S100B determination in the management of pediatric mild traumatic brain injury. Clinical Chemistry 2012;58:1116–1122
   PubMed Web of Science ®Google Scholar
• Calcagnile O, Unden L, Unden J. Clinical validation of S100B use in management of mild head injury. BMC Emergency Medicine 2012;12:13
   PubMedGoogle Scholar
• Castellani C, Bimbashi P, Ruttenstock E, Sacherer P, Stojakovic T, Weinberg AM. Neuroprotein s-100B -- a useful parameter in paediatric patients with mild traumatic brain injury? Acta Paediatrica 2009;98:1607–1612
   PubMed Web of Science ®Google Scholar
• de Boussard CN, Lundin A, Karlstedt D, Edman G, Bartfai A, Borg J. S100 and cognitive impairment after mild traumatic brain injury. Journal of Rehabilitation Medicine 2005;37:53–57
   PubMed Web of Science ®Google Scholar
• de Kruijk JR, Leffers P, Menheere PP, Meerhoff S, Twijnstra A. S-100B and neuron-specific enolase in serum of mild traumatic brain injury patients. A comparison with health controls. Acta Neurologica Scandinavica 2001;103:175–179
   PubMed Web of Science ®Google Scholar
• Geyer C, Ulrich A, Grafe G, Stach B, Till H. Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury. Journal of Neurosurgery: Pediatrics 2009;4:339–344
   PubMed Web of Science ®Google Scholar
• Hinkle DA, Baldwin SA, Scheff SW, Wise PM. GFAP and S100beta expression in the cortex and hippocampus in response to mild cortical contusion. Journal of Neurotrauma 1997;14:729–738
   PubMed Web of Science ®Google Scholar
• Ingebrigtsen T, Romner B. Should brain injury markers replace CT in mild head injury? Tidsskr Nors Laegeforen 2012;132:1948–1949
   PubMedGoogle Scholar
• Kleinert K, Schleich F, Biasca N, Simmen HP. Is there a correlation between S100 beta and post-concussion symptoms after mild traumatic brain injury? Zentralbl Chir 2010;135:277–278
   PubMed Web of Science ®Google Scholar
• Leidel BA, Bogner V, Zock M, Kanz KG. Serological determination of protein S100B. Significance in emergency diagnosis of adults with mild craniocerebral trauma--meta-analysis. Der Unfallchirurg 2012;115:903–912
   PubMedGoogle Scholar
• Lima DP, Simao Filho C, Abib Sde C, de Figueiredo LF. Quality of life and neuropsychological changes in mild head trauma. Late analysis and correlation with S100B protein and cranial CT scan performed at hospital admission. Injury 2008;39:604–611
   PubMed Web of Science ®Google Scholar
• Metting Z, Wilczak N, Rodiger LA, Schaaf JM, van der Naalt J. GFAP and S100B in the acute phase of mild traumatic brain injury. Neurology 2012;78:1428–1433
   PubMed Web of Science ®Google Scholar
• Morochovic R, Rácz O, Kitka M, Pingorová S, Cibur P, Tomková D, Lenártová R. Serum S100B protein in early management of patients after mild traumatic brain injury. European Journal of Neurology 2009;16:1112–1117
   PubMed Web of Science ®Google Scholar
• Müller K, Ingebrigtsen T, Wilsgaard T, Wikran G, Fagerheim T, Romner B, Waterloo K. Prediction of time trends in recovery of cognitive function after mild head injury. Neurosurgery 2009;64:698–704
   PubMed Web of Science ®Google Scholar
• Nygren De Boussard C, Fredman P, Lundin A, Andersson K, Edman G, Borg J. S100 in mild traumatic brain injury. Brain Injury 2004;18:671–683
   PubMed Web of Science ®Google Scholar
• Ruan S, Noyes K, Bazarian JJ. The economic impact of S-100B as a pre-head CT screening test on emergency department management of adult patients with mild traumatic brain injury. Journal of Neurotrauma 2009;26:1655–1664
   PubMed Web of Science ®Google Scholar
• Savola O, Hillbom M. Early predictors of post-concussion symptoms in patients with mild head injury. European Journal of Neurology 2003;10:175–181
   PubMed Web of Science ®Google Scholar
• Shima K. Clinical standard of neurosurgical disorder. (2) Management of mild traumatic brain injury. No Shinkei Geka 2009;37:95–104
   PubMedGoogle Scholar
• Sojka P, Stalnacke BM, Bjornstig U, Karlsson K. One-year follow-up of patients with mild traumatic brain injury: Occurrence of post-traumatic stress-related symptoms at follow-up and serum levels of cortisol, S-100B and neuron-specific enolase in acute phase. Brain Injury 2006;20:613–620
   PubMed Web of Science ®Google Scholar
• Stalnacke BM, Bjornstig U, Karlsson K, Sojka P. One-year follow-up of mild traumatic brain injury: Post-concussion symptoms, disabilities and life satisfaction in relation to serum levels of S-100B and neurone-specific enolase in acute phase. Journal of Rehabilitation Medicine 2005;37:300–305
   PubMed Web of Science ®Google Scholar
• Stapert S, de Kruijk J, Houx P, Menheere P, Twijnstra A, Jolles J. S-100B concentration is not related to neurocognitive performance in the first month after mild traumatic brain injury. European Neurology 2005;53:22–26
   PubMed Web of Science ®Google Scholar
• Stranjalis G, Korfias S, Papapetrou C, Kouyialis A, Boviatsis E, Psachoulia C, Sakas DE. Elevated serum S-100B protein as a predictor of failure to short-term return to work or activities after mild head injury. Journal of Neurotrauma 2004;21:1070–1075
   PubMed Web of Science ®Google Scholar
• Talypov AE, Puras IuV, Godkov MA, Sharifullin FA, Kuksova NS, Sosnovskiĭ EA, Krylov VV. Levels of S100beta protein in patients with mild traumatic brain injury. Journal of Trauma and Acute Care Surgery 2010;110:4–8
   Google Scholar
• Topolovec-Vranic J, Pollmann-Mudryj MA, Ouchterlony D, Klein D, Spence J, Romaschin A, Rhind S, Tien HC, Baker AJ. The value of serum biomarkers in prediction models of outcome after mild traumatic brain injury. Journal of Trauma 2011;71(5 Suppl 1):S478–S486
   Google Scholar
• Wolf H, Frantal S, Pajenda GS, Salameh O, Widhalm H, Hajdu S, Sarahrudi K. Predictive value of neuromarkers supported by a set of clinical criteria in patients with mild traumatic brain injury: S100B protein and neuron-specific enolase on trial: Clinical article. Journal of Neurosurgery 2013;118:1298–1303
   PubMed Web of Science ®Google Scholar
• Beaudeux JL. S100B protein: A novel biomarker for the diagnosis of head injury. Annals of Pharmaceutiques Francaises 2009;67:187–194
   PubMedGoogle Scholar
• Beharier O, Kahn J, Shusterman E, Sheiner E. S100B - a potential biomarker for early detection of neonatal brain damage following asphyxia. Journal of Maternal-Fetal & Neonatal Medicine 2012;25:1523–1538
   PubMed Web of Science ®Google Scholar
• Bennet L, Booth L, Gunn AJ. Potential biomarkers for hypoxic-ischemic encephalopathy. Seminars in Fetal & Neonatal Medicine 2010;15:253–260
   PubMed Web of Science ®Google Scholar
• Berger R. Biomarkers or neuroimaging in central nervous system injury: Will the real “gold standard” please stand up? Pediatric Critical Care Medicine 2003;4:391–392
   PubMedGoogle Scholar
• Bramanti V, Tomassoni D, Avitabile M, Amenta F, Avola R. Biomarkers of glial cell proliferation and differentiation in culture. Frontiers in Bioscience (Scholar Edition) 2010;2:558–570
   PubMedGoogle Scholar
• Cata JP, Abdelmalak B, Farag E. Neurological biomarkers in the perioperative period. British Journal of Anaesthesia 2011;107:844–858
   PubMed Web of Science ®Google Scholar
• Einav S, Kaufman N, Algur N, Kark JD. Modeling serum biomarkers S100 beta and neuron-specific enolase as predictors of outcome after out-of-hospital cardiac arrest: An aid to clinical decision making. Journal of the American College of Cardiology 2012;60:304–311
   PubMed Web of Science ®Google Scholar
• Fenton K. Sepsis and the BBB: Brain injury, biomarkers, and the bedside. Critical Care Medicine 2006;34:2022–2023
   PubMed Web of Science ®Google Scholar
• Finnoff JT, Jelsing EJ, Smith J. Biomarkers, genetics, and risk factors for concussion. Physical Medicine & Rehabilitation 2011;3(10 Suppl 2):S452–459
   Google Scholar
• Graham MR, Myers T, Evans P, Davies B, Cooper SM, Bhattacharya K, Grace FM, Baker JS. Direct hits to the head during amateur boxing is associated with a rise in serum biomarkers for brain injury. International Journal of Immunopathology & Pharmacology 2011;24:119–125
   PubMed Web of Science ®Google Scholar
• Laskowitz DT, Kasner SE, Saver J, Remmel KS, Jauch EC, Group BS. Clinical usefulness of a biomarker-based diagnostic test for acute stroke: The Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study. Stroke 2009;40:77–85
   PubMed Web of Science ®Google Scholar
• Liao CW, Fan CK, Kao TC, Ji DD, Su KE, Lin YH, Cho WL. Brain injury-associated biomarkers of TGF-beta1, S100B, GFAP, NF-L, tTG, AbetaPP, and tau were concomitantly enhanced and the UPS was impaired during acute brain injury caused by Toxocara canis in mice. BMC Infectious Diseases 2008;8:84
   PubMedGoogle Scholar
• Lo TY, Jones PA, Minns RA. Combining coma score and serum biomarker levels to predict unfavorable outcome following childhood brain trauma. Journal of Neurotrauma 2010;27:2139–2145
   PubMed Web of Science ®Google Scholar
• Massaro AN, Chang T, Kadom N, Tsuchida T, Scafidi J, Glass P, McCarter R, Baumgart S, Vezina G, Nelson KB. Biomarkers of brain injury in neonatal encephalopathy treated with hypothermia. Journal of Pediatrics 2012;161:434–440
   PubMed Web of Science ®Google Scholar
• Michetti F, Corvino V, Geloso MC, Lattanzi W, Bernardini C, Serpero L, Gazzolo D. The S100B protein in biological fluids: More than a lifelong biomarker of brain distress. Journal of Neurochemistry 2012;120:644–659
   PubMed Web of Science ®Google Scholar
• Neselius S, Brisby H, Theodorsson A, Blennow K, Zetterberg H, Marcusson J. CSF-biomarkers in Olympic boxing: Diagnosis and effects of repetitive head trauma. PLoS One 2012;7:e33606
   PubMed Web of Science ®Google Scholar
• Niyonkuru C, Wagner AK, Ozawa H, Amin K, Goyal A, Fabio A. Group-based trajectory analysis applications for prognostic biomarker model development in severe TBI: A practical example. Journal of Neurotrauma 2013;30:938–945
   PubMed Web of Science ®Google Scholar
• Palmio J, Huuhka M, Laine S, Huhtala H, Peltola J, Leinonen E, Suhonen J, Keränen T. Electroconvulsive therapy and biomarkers of neuronal injury and plasticity: Serum levels of neuron-specific enolase and S-100b protein. Psychiatry Research 2010;177:97–100
   PubMed Web of Science ®Google Scholar
• Petzold A, Stiefel D, Copp AJ. Amniotic fluid brain-specific proteins are biomarkers for spinal cord injury in experimental myelomeningocele. Journal of Neurochemistry 2005;95:594–598
   PubMed Web of Science ®Google Scholar
• Ramaswamy V, Horton J, Vandermeer B, Buscemi N, Miller S, Yager J. Systematic review of biomarkers of brain injury in term neonatal encephalopathy. Pediatric Neurology 2009;40:215–226
   PubMed Web of Science ®Google Scholar
• Redl H, Pelinka L, Bahrami S. To be or not to be--a biomarker of brain damage in sepsis. Pediatric Critical Care Medicine 2008;9:337–339
   PubMed Web of Science ®Google Scholar
• Risso FM, Sannia A, Gavilanes DA, Vles HJ, Colivicchi M, Ricotti A, Li Volti G, Gazzolo D. Biomarkers of brain damage in preterm infants. Journal of Maternal-Fetal & Neonatal Medicine 2012;25(Suppl 4):101–104
   PubMedGoogle Scholar
• Sanfilippo F, Li Volti G, Ristagno G, Murabito P, Pellis T, Astuto M, Gullo A. Clinical biomarkers in brain injury: A lesson from cardiac arrest. Frontiers in Biosciences (Scholar Edition) 2010;2:623–640
   PubMedGoogle Scholar
• Seco M, Edelman JJ, Wilson MK, Bannon PG, Vallely MP. Serum biomarkers of neurologic injury in cardiac operations. Annals of Thoracic Surgery 2012;94:1026–1033
   PubMed Web of Science ®Google Scholar
• Shirasaki Y, Edo N, Sato T. Serum S-100b protein as a biomarker for the assessment of neuroprotectants. Brain Research 2004;1021:159–166
   PubMed Web of Science ®Google Scholar
• Taira BR. Annals of Emergency Medicine Journal Club. Biomarkers revisited: Study design, validity and STARD. Will S100-B impact computed tomography use in head injury patients? Annals of Emergency Medicine 2012;59:221–222
   PubMed Web of Science ®Google Scholar
• Taira BR, Schriger DL. Annals of Emergency Medicine Journal Club. Biomarkers revisited: Study design, validity, and STARD: Will S100-B affect computed tomography use in head injury patients?: Answers to the March 2012 Journal Club questions. Annals of Emergency Medicine 2012;60:236–240
   PubMed Web of Science ®Google Scholar
• Tasker RC. Validating serologic biomarkers of brain injury for cardiac arrest research. Pediatric Critical Care Medicine 2009;10:529–530
   PubMed Web of Science ®Google Scholar
• Undén J, Strandberg K, Malm J, Campbell E, Rosengren L, Stenflo J, Norrving B, Romner B, Lindgren A, Andsberg G. Explorative investigation of biomarkers of brain damage and coagulation system activation in clinical stroke differentiation. Journal of Neurology 2009;256:72–77
   PubMed Web of Science ®Google Scholar
• Ingebrigtsen T, Waterloo K, Jacobsen EA, Langbakk B, Romner B. Traumatic brain damage in minor head injury: Relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehavioral outcome. Neurosurgery 1999;45:468–475
   PubMed Web of Science ®Google Scholar
• Mussack T, Biberthaler P, Wiedemann E, Kanz KG, Englert A, Gippner-Steppert C, Jochum M. S-100b as a screening marker of the severity of minor head trauma (MHT)--a pilot study. Acta Neurochirurgica Supplement 2000;76:393–396
   PubMedGoogle Scholar
• Romner B, Ingebrigtsen T, Kongstad P, Borgesen SE. Traumatic brain damage: Serum S-100 protein measurements related to neuroradiological findings. Journal of Neurotrauma 2000;17:641–647
   PubMed Web of Science ®Google Scholar
• Herrmann M. High serum S100B levels for trauma patients without head injuries. Neurosurgery 2001;49:1272–1273
   PubMed Web of Science ®Google Scholar
• de Kruijk J, Leffers P, Menheere P, Meerhoff S, Rutten J, Twijnstra A. Prediction of post-traumatic complaints after mild traumatic brain injury: Early symptoms and biochemical markers. Journal of Neurology, Neurosurgery & Psychiatry 2002;73:727–732
   PubMed Web of Science ®Google Scholar
• Mussack T, Biberthaler P, Kanz KG, Heckl U, Gruber R, Linsenmaier U, Mutschler W, Jochum M. Immediate S-100B and neuron-specific enolase plasma measurements for rapid evaluation of primary brain damage in alcohol-intoxicated, minor head-injured patients. Shock 2002;18:395–400
   PubMed Web of Science ®Google Scholar
• Savola O, Hillbom M. Early predictors of post-concussion symptoms in patients with mild head injury. European Journal of Neurology 2003;10:175–181
   PubMed Web of Science ®Google Scholar
• Poli-de-Figueiredo LF, Biberthaler P, Simao Filho C, Hauser C, Mutschler W, Jochum M. Measurement of S-100B for risk classification of victims sustaining minor head injury--first pilot study in Brazil. Clinics (Sao Paulo) 2006;61:41–46
   PubMedGoogle Scholar
• Stranjalis G, Korfias S, Psachoulia C, Kouyialis A, Sakas DE, Mendelow AD. The prognostic value of serum S-100B protein in spontaneous subarachnoid haemorrhage. Acta Neurochirurgica (Wien) 2007;149:231–237
   PubMed Web of Science ®Google Scholar
• Schultke E, Sadanand V, Kelly ME, Griebel RW, Juurlink BH. Can admission S-100beta predict the extent of brain damage in head trauma patients? Canadian Journal of Neurological Sciences 2009;36:612–616
   PubMed Web of Science ®Google Scholar
• Muller B, Evangelopoulos DS, Bias K, Wildisen A, Zimmermann H, Exadaktylos AK. Can S-100B serum protein help to save cranial CT resources in a peripheral trauma centre? A study and consensus paper. Emergency Medicine Journal 2011;28:938–940
   PubMed Web of Science ®Google Scholar
• Egea-Guerrero JJ, Revuelto-Rey J, Murillo-Cabezas F, Muñoz-Sánchez MA, Vilches-Arenas A, Sánchez-Linares P, Domínguez-Roldán JM, León-Carrión J. Accuracy of the S100beta protein as a marker of brain damage in traumatic brain injury. Brain Injury 2012;26:76–82
   PubMed Web of Science ®Google Scholar
• Zongo D, Ribéreau-Gayon R, Masson F, Laborey M, Contrand B, Salmi LR, Montaudon D, Beaudeux JL, Meurin A, Dousset V, Loiseau H, Lagarde E. S100-B protein as a screening tool for the early assessment of minor head injury. Annals of Emergency Medicine 2012;59:209–218
   PubMed Web of Science ®Google Scholar
• Müller K, Townend W, Biasca N, Undén J, Waterloo K, Romner B, Ingebrigtsen T. S100B serum level predicts computed tomography findings after minor head injury. Journal of Trauma & Acute Care Surgery 2007;62:1452–1456
   Google Scholar
• Bazarian JJ, Blyth BJ, He H, Mookerjee S, Jones C, Kiechle K, Moynihan R, Wojcik SM, Grant WD, Secreti LM, et al. Classification accuracy of serum Apo A-I and S100B for the diagnosis of mild traumatic brain injury and prediction of abnormal initial head computed tomography scan. Journal of Neurotrauma 2013;30:1747–1754
   PubMed Web of Science ®Google Scholar
• Stranjalis G, Korfias S, Psachoulia C, Kouyialis A, Sakas D, Mendelow A. The prognostic value of serum S-100B protein in spontaneous subarachnoid haemorrhage. Acta Neurochirurgica (Wien) 2007;149:231–238
   PubMed Web of Science ®Google Scholar
• De Boussard C, Fredman P, Lundin A, Andersson K, Edman G, Borg J. S100 in mild traumatic brain injury. Brain Injury 2004;18:671–683
   PubMed Web of Science ®Google Scholar
• Cervellin G, Benatti M, Carbucicchio A, Mattei L, Cerasti D, Aloe R, Lippi G. Serum levels of protein S100B predict intracranial lesions in mild head injury. Clinical Biochemistry 2012;45:408–411
   PubMed Web of Science ®Google Scholar
• Bechtel K, Frasure S, Marshall C, Dziura J, Simpson C. Relationship of serum S100B levels and intracranial injury in children with closed head trauma. Pediatrics 2009;124:e697–e670104
   PubMed Web of Science ®Google Scholar
• Asadollahi S, Heidari K, Hatamabadi H, Jamshidian M, Vafaee A, Manoochehri M, Mohammad Seidabadi A, Habibzade Shojaee A, Nezafat T. Reducing head computed tomography after mild traumatic brain injury: Screening value of clinical findings and S100B protein levels. Manuscript submitted for publication. 2014
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Annals of Internal Medicine 2009;151:264–269
   PubMed Web of Science ®Google Scholar
• Müller K, Townend W, Biasca N, Undén J, Waterloo K, Romner B, Ingebrigtsen T. S100B serum level predicts computed tomography findings after minor head injury. Journal of Trauma 2007;62:1452–1456
   PubMed Web of Science ®Google Scholar
• Jagoda AS, Bazarian JJ, Bruns JJ Jr., Cantrill SV, Gean AD, Howard PK, Ghajar J, Riggio S, Wright DW, Wears RL, et al. Clinical policy: Neuroimaging and decisionmaking in adult mild traumatic brain injury in the acute setting. Journal of Emergency Nursing 2009;35:e5–e40
   PubMedGoogle Scholar
• Hall EJ, Brenner DJ. Cancer risks from diagnostic radiology. British Journal of Radiology 2008;81:362–378
   PubMed Web of Science ®Google Scholar
• Kuppermann N, Holmes JF, Dayan PS, Hoyle JD Jr., Atabaki SM, Holubkov R, Nadel FM, Monroe D, Stanley RM, Borgialli DA, et al. Identification of children at very low risk of clinically-important brain injuries after head trauma: A prospective cohort study. The Lancet 2009;374:1160–1170
   PubMed Web of Science ®Google Scholar
• Papa L, Ramia MM, Kelly JM, Burks SS, Pawlowicz A, Berger RP. Systematic review of clinical research on biomarkers for pediatric traumatic brain injury. Journal of Neurotrauma 2013;30:324–338
   PubMed Web of Science ®Google Scholar
• Filippidis AS, Papadopoulos DC, Kapsalaki EZ, Fountas KN. Role of the S100B serum biomarker in the treatment of children suffering from mild traumatic brain injury. Neurosurgical Focus 2010;29:E2
   PubMed Web of Science ®Google Scholar
• Bouvier D, Castellani C, Fournier M, Dauphin JB, Ughetto S, Breton M, Labbé A, Weinberg AM, Sapin V. Reference ranges for serum S100B protein during the first three years of life. Clinical Biochemistry2011;44:927–929
   PubMed Web of Science ®Google Scholar